PubRank

Mary-Margaret Chren

Author PubWeight™ 61.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 2006 6.66
2 Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med 2013 4.59
3 Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004 3.43
4 Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ 2012 2.43
5 Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007 1.73
6 Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol 2011 1.52
7 Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 2011 1.51
8 Characteristics and impact of drug detailing for gabapentin. PLoS Med 2007 1.51
9 Cognitive screening predicts magnitude of functional recovery from admission to 3 months after discharge in hospitalized elders. J Gerontol A Biol Sci Med Sci 2003 1.24
10 Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg 2009 1.17
11 A clinical index to stratify hospitalized older adults according to risk for new-onset disability. J Am Geriatr Soc 2011 1.16
12 Effects of atopic dermatitis on young American children and their families. Pediatrics 2004 1.15
13 Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg 2011 1.10
14 Acute care for elders units produced shorter hospital stays at lower cost while maintaining patients' functional status. Health Aff (Millwood) 2012 1.09
15 What's in a name? Use of brand versus generic drug names in United States outpatient practice. J Gen Intern Med 2007 1.07
16 The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 2005 1.06
17 Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2004 1.05
18 Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol 2010 1.03
19 Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol 2009 1.01
20 Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol 2009 1.01
21 Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006 0.99
22 The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002 0.96
23 Effects of vulvodynia on quality of life. J Am Acad Dermatol 2008 0.95
24 Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control 2010 0.95
25 Turkish version of Skindex-29. Int J Dermatol 2007 0.94
26 Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. Cancer Causes Control 2011 0.93
27 Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg 2004 0.92
28 Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004 0.89
29 Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol 2012 0.88
30 Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. Clin J Am Soc Nephrol 2006 0.88
31 Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002 0.87
32 Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin North Am 2010 0.85
33 Predictors of patient satisfaction with Mohs surgery: analysis of preoperative, intraoperative, and postoperative factors in a prospective cohort. Arch Dermatol 2011 0.84
34 Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005 0.84
35 A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol 2007 0.83
36 Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer 2011 0.82
37 Statin use and risk of basal cell carcinoma. J Am Acad Dermatol 2009 0.82
38 Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma. JAMA Dermatol 2013 0.82
39 Acne severity grading: determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol 2011 0.81
40 Itch as a patient-reported symptom in ambulatory care visits in the United States. J Am Acad Dermatol 2013 0.81
41 Use of a cane for ambulation: marker and mitigator of impairment in older people who report no difficulty walking. J Am Geriatr Soc 2002 0.80
42 Out of the skin of babes: measuring the full impact of atopic dermatitis in infants and young children. J Invest Dermatol 2012 0.79
43 Effect of store and forward teledermatology on quality of life: a randomized controlled trial. JAMA Dermatol 2013 0.79
44 Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus. JAMA Dermatol 2013 0.78
45 Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic. Arch Dermatol 2008 0.78
46 Conceptual issues in measuring the burden of skin diseases. J Investig Dermatol Symp Proc 2004 0.77
47 Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol 2007 0.76
48 Adaptation of a Runyankore version of Skindex-16 for oral administration in Mbarara, Uganda. Int J Dermatol 2011 0.75
49 Doctor's orders: rethinking compliance in dermatology. Arch Dermatol 2002 0.75
50 Determining the value of surgical therapies for basal cell carcinoma. Arch Dermatol 2006 0.75
51 Evaluating clinical rating scales for evidence-based dermatology: some basic concepts. Dermatol Clin 2005 0.75
52 Skin-related quality of life in HIV-infected patients on highly active antiretroviral therapy. J Cutan Med Surg 2002 0.75